Prothena Announces Departure of Chief Medical Officer

DUBLIN, Ireland, Feb. 02, 2018 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, announced today that Sarah Noonberg, MD, PhD, has decided to resign from her position as Chief Medical Officer.  She will provide Prothena […]